Emiba is an international scientific and technical business project. The aim is the synthesis of new materials with extreme properties for the industry, including synthetic diamonds using ultrahigh pressures. The concentrator is a device for obtaining and retaining ultrahigh pressures developed by a group of Russian engineers in the early 2000s. All patent rights and commercial names belong to the Emiba project. The main goal of the project is the organization of a highly profitable business and production based on its own designed device (Concentrator) to intend for the synthesis of new materials using ultrahigh pressure. The planned organizational and legal form of business is a joint-stock company with further distribution of profit among shareholders-investors. The commercial goal is to reduce the cost of production of diamond raw for processors' and chips’ substrates for microelectronics in comparison with existing synthesis technologies. Additional is the possibility of economical and safe creating other raw materials as borazon, polymers and new stable crystalline structures of high importance with significant prospects in terms of practical application in many industries.
Friends, today we will talk about the benefits of rough diamonds in medicine. 🔻 Magnetic resonance imaging is one of the most effective ways to diagnose various diseases as it allows to obtain a layer-by-layer image of the internal organs. Read more in FB:https://web.facebook.com/emiba.global/posts/929111280758988
All information presented on the website regarding the description of ICO projects, cost, and investment opportunities is for informational purposes only and is not a public offer under any circumstances.
By investing in this ICO you agree to the User Agreement